I. Kalickman

582 total citations
10 papers, 498 citations indexed

About

I. Kalickman is a scholar working on Immunology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I. Kalickman has authored 10 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 2 papers in Genetics and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I. Kalickman's work include Chronic Lymphocytic Leukemia Research (2 papers), Ocular Oncology and Treatments (2 papers) and Oral microbiology and periodontitis research (1 paper). I. Kalickman is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Ocular Oncology and Treatments (2 papers) and Oral microbiology and periodontitis research (1 paper). I. Kalickman collaborates with scholars based in Israel, United States and Italy. I. Kalickman's co-authors include Vivian Barak, V. Barak, Benjamin Nisman, Aya Abrahamov, Ari Zimran, S Yatziv, Yehuda Shoenfeld, M. Eric Gershwin, Miri Blank and Hartmut Engelmann and has published in prestigious journals such as Transplantation, Investigative Ophthalmology & Visual Science and Clinical & Experimental Immunology.

In The Last Decade

I. Kalickman

10 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Kalickman Israel 8 153 122 115 110 65 10 498
Jan Klapproth Germany 8 48 0.3× 197 1.6× 204 1.8× 112 1.0× 24 0.4× 9 639
Kiki Schraa Netherlands 11 123 0.8× 333 2.7× 159 1.4× 178 1.6× 24 0.4× 20 678
Theodor Kudlich Germany 12 101 0.7× 207 1.7× 146 1.3× 283 2.6× 48 0.7× 23 806
G. P. Fiori Italy 13 62 0.4× 67 0.5× 83 0.7× 154 1.4× 18 0.3× 31 455
Kyoko Takahashi Japan 15 122 0.8× 292 2.4× 162 1.4× 71 0.6× 23 0.4× 34 624
Merav Strauss Israel 10 138 0.9× 220 1.8× 86 0.7× 157 1.4× 252 3.9× 22 722
Ulf Hindorf Sweden 14 47 0.3× 74 0.6× 45 0.4× 264 2.4× 68 1.0× 22 916
Johannes Barsig Germany 14 200 1.3× 335 2.7× 427 3.7× 121 1.1× 10 0.2× 19 946

Countries citing papers authored by I. Kalickman

Since Specialization
Citations

This map shows the geographic impact of I. Kalickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Kalickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Kalickman more than expected).

Fields of papers citing papers by I. Kalickman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Kalickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Kalickman. The network helps show where I. Kalickman may publish in the future.

Co-authorship network of co-authors of I. Kalickman

This figure shows the co-authorship network connecting the top 25 collaborators of I. Kalickman. A scholar is included among the top collaborators of I. Kalickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Kalickman. I. Kalickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Barak, Vivian, I. Kalickman, & Jacob Pe’er. (2022). sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma. Anticancer Research. 42(3). 1447–1453. 4 indexed citations
2.
Barak, Vivian, Carlo Selmi, M Schlesinger, et al.. (2009). Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. Journal of Autoimmunity. 33(3-4). 178–182. 68 indexed citations
3.
Barak, Vivian, Igor Kaiserman, Shahar Frenkel, et al.. (2008). The Dynamics of Serum Biomarkers and Their Role in Predicting Metastatic Uveal Melanoma. Investigative Ophthalmology & Visual Science. 49(13). 1500–1500. 2 indexed citations
4.
Shapira, Joseph, et al.. (2004). Cytokine levels in gingival crevicular fluid of erupting primary teeth correlated with systemic disturbances accompanying teething.. PubMed. 25(5). 441–8. 35 indexed citations
5.
Barak, Vivian, et al.. (2001). The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines.. PubMed. 12(2). 290–6. 90 indexed citations
6.
Barak, V., Benjamin Nisman, I. Kalickman, et al.. (1999). Cytokines in Gaucher's disease.. PubMed. 10(2). 205–10. 154 indexed citations
7.
Nagler, Arnon, et al.. (1995). ELEVATED INFLAMMATORY CYTOKINE LEVELS IN BONE MARROW GRAFT REJECTION. Transplantation. 60(9). 943–948. 30 indexed citations
8.
Nisman, Benjamin, et al.. (1994). Serum interleukin 1 beta levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels.. PubMed. 14 Suppl 1. 33–9. 7 indexed citations
10.
Kalinkovich, Alexander, Hartmut Engelmann, Noam Harpaz, et al.. (1992). Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clinical & Experimental Immunology. 89(3). 351–355. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026